Nova Mentis Organizes Autism Data Bank in North America Post published:April 20, 2021 Post category:Press Release
Tryp Therapeutics Reports on Key Milestones for 2021 Post published:April 20, 2021 Post category:Press Release
Silo Wellness Appoints Phytomedicine Business Leader as Board Member Post published:April 20, 2021 Post category:Press Release
PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease Post published:April 20, 2021 Post category:Press Release
Beckley Psytech partners with Fluence to create psychedelic therapy training programme Post published:April 20, 2021 Post category:Press Release
PharmaTher Provides Update on Psychedelic Product Programs Post published:April 15, 2021 Post category:Press Release
Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brasil Post published:April 15, 2021 Post category:Press Release
New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder Post published:April 15, 2021 Post category:Press Release
Albert Labs Appoints Mackie Research As Lead Agent For Private Placement Of Proceeds Up To $4 Million Pre-RTO Post published:April 14, 2021 Post category:Press Release